Huaren Pharmaceutical Co., Ltd. (SHE:300110)
China
· Delayed Price · Currency is CNY 3.280
-0.020 (-0.61%)
Mar 11, 2026, 10:25 AM CST
Huaren Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -1,409 | -1,368 | 188.06 | 180.78 | 130.4 | 94.62 | Upgrade
|
| Depreciation & Amortization | 116.68 | 116.68 | 126.85 | 149.59 | 134.94 | 113.45 | Upgrade
|
| Other Amortization | 10.25 | 10.25 | 8.55 | 11.02 | 16.45 | 16.94 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.02 | -0.02 | -4.35 | -13.86 | -0.11 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 87.57 | 87.57 | 7.03 | 6.69 | 0.28 | 0.04 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.36 | -0.36 | -0.84 | 1.39 | 0.87 | -0.71 | Upgrade
|
| Provision & Write-off of Bad Debts | 9.86 | 9.86 | -48.21 | 38.66 | 42.19 | 38.92 | Upgrade
|
| Other Operating Activities | 1,424 | 1,412 | 130.73 | 75.7 | 111.27 | 24.02 | Upgrade
|
| Change in Accounts Receivable | 172.59 | 172.59 | 9.02 | 135.83 | -1,307 | -345.47 | Upgrade
|
| Change in Inventory | 9.11 | 9.11 | -58.03 | 8.62 | -2.18 | -33.75 | Upgrade
|
| Change in Accounts Payable | -108.13 | -108.13 | -63.84 | -361.01 | 303.49 | 81.32 | Upgrade
|
| Operating Cash Flow | 293.6 | 322.36 | 305.6 | 217.98 | -578.52 | -10.74 | Upgrade
|
| Operating Cash Flow Growth | -25.47% | 5.49% | 40.19% | - | - | - | Upgrade
|
| Capital Expenditures | -44.12 | -24.69 | -45.86 | -42.33 | -27.86 | -57.96 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.02 | 0.03 | 10.03 | 26.43 | 0.07 | - | Upgrade
|
| Cash Acquisitions | - | -13.67 | -61.61 | -128 | -431.8 | -186.35 | Upgrade
|
| Divestitures | 1.71 | - | - | - | - | - | Upgrade
|
| Investment in Securities | 0.06 | 0.06 | - | - | - | 2.85 | Upgrade
|
| Other Investing Activities | 0.36 | 0.36 | 0.3 | 0.09 | 1.01 | 3.49 | Upgrade
|
| Investing Cash Flow | -41.97 | -37.92 | -97.14 | -143.81 | -458.58 | -237.97 | Upgrade
|
| Long-Term Debt Issued | - | 843.33 | 1,498 | 2,010 | 1,995 | 360 | Upgrade
|
| Long-Term Debt Repaid | - | -1,129 | -1,606 | -2,179 | -694 | -202.7 | Upgrade
|
| Net Debt Issued (Repaid) | -134.14 | -285.79 | -108.26 | -169.12 | 1,301 | 157.3 | Upgrade
|
| Common Dividends Paid | -46.32 | -78.9 | -86.15 | -89.38 | -71.38 | -22.46 | Upgrade
|
| Other Financing Activities | -4.66 | -4.82 | 73.69 | 105.84 | -189.23 | -22.49 | Upgrade
|
| Financing Cash Flow | -185.13 | -369.5 | -120.72 | -152.67 | 1,040 | 112.35 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.24 | 0 | -0 | -0 | -0.02 | 0.03 | Upgrade
|
| Net Cash Flow | 66.26 | -85.07 | 87.74 | -78.5 | 3.03 | -136.33 | Upgrade
|
| Free Cash Flow | 249.48 | 297.67 | 259.74 | 175.65 | -606.38 | -68.71 | Upgrade
|
| Free Cash Flow Growth | -30.39% | 14.60% | 47.87% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 19.87% | 22.00% | 15.87% | 10.85% | -38.85% | -5.22% | Upgrade
|
| Free Cash Flow Per Share | 0.21 | 0.25 | 0.22 | 0.15 | -0.51 | -0.06 | Upgrade
|
| Cash Income Tax Paid | 113.42 | 138.89 | 183.31 | 146.47 | 183.03 | 162.12 | Upgrade
|
| Levered Free Cash Flow | 2,251 | 1,632 | 293.17 | 143.72 | -634.17 | -30.09 | Upgrade
|
| Unlevered Free Cash Flow | 2,279 | 1,666 | 331.61 | 183.82 | -594.71 | -23.24 | Upgrade
|
| Change in Working Capital | 55.04 | 55.04 | -102.22 | -231.97 | -1,015 | -298.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.